| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
52,822 |
46,423 |
$2.04M |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
14,877 |
12,839 |
$633K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
10,906 |
9,608 |
$622K |
| 96127 |
|
45,473 |
33,366 |
$521K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
12,494 |
11,383 |
$469K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
5,646 |
5,199 |
$386K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
4,982 |
4,402 |
$329K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
3,416 |
3,015 |
$214K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
13,096 |
12,256 |
$126K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
4,659 |
3,770 |
$125K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
12,225 |
5,699 |
$114K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,389 |
1,187 |
$102K |
| 99177 |
|
10,554 |
9,245 |
$87K |
| 92558 |
|
7,470 |
6,657 |
$60K |
| 92551 |
|
5,962 |
5,203 |
$55K |
| 96161 |
|
3,126 |
2,658 |
$52K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
301 |
281 |
$23K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
560 |
531 |
$21K |
| 92588 |
|
376 |
353 |
$20K |
| 99215 |
Prolong outpt/office vis |
169 |
152 |
$15K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
94 |
90 |
$7K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
414 |
388 |
$5K |
| 99173 |
|
1,468 |
1,393 |
$4K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
193 |
188 |
$4K |
| 96160 |
|
113 |
104 |
$3K |
| 36416 |
|
1,664 |
1,509 |
$3K |
| 3008F |
|
16,417 |
14,467 |
$3K |
| 90686 |
|
2,358 |
2,071 |
$2K |
| 90670 |
|
1,887 |
1,655 |
$2K |
| 83655 |
|
218 |
200 |
$2K |
| 85018 |
|
833 |
751 |
$2K |
| 90677 |
|
464 |
397 |
$2K |
| 80061 |
Lipid panel |
113 |
92 |
$2K |
| 97802 |
|
195 |
161 |
$1K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
13 |
13 |
$1K |
| 90651 |
|
264 |
201 |
$1K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
68 |
66 |
$968.27 |
| 90671 |
|
338 |
255 |
$687.81 |
| 69210 |
|
13 |
12 |
$520.55 |
| 81003 |
|
321 |
286 |
$516.83 |
| 90619 |
|
90 |
56 |
$504.88 |
| 94760 |
|
288 |
247 |
$406.71 |
| 85014 |
|
206 |
189 |
$402.40 |
| 90716 |
|
232 |
212 |
$366.28 |
| 90697 |
|
436 |
351 |
$327.56 |
| 92587 |
|
12 |
12 |
$290.24 |
| 90661 |
|
414 |
365 |
$178.61 |
| 90707 |
|
215 |
200 |
$167.54 |
| 90633 |
|
492 |
451 |
$167.11 |
| 90734 |
|
41 |
32 |
$162.85 |
| 90698 |
|
263 |
232 |
$127.31 |
| 90688 |
|
65 |
62 |
$71.24 |
| 90715 |
|
50 |
36 |
$55.96 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
39 |
38 |
$3.09 |
| 99072 |
|
3,046 |
2,858 |
$1.89 |
| 90680 |
|
417 |
350 |
$1.00 |
| 90681 |
|
16 |
13 |
$0.00 |
| 90685 |
|
29 |
29 |
$0.00 |
| 90674 |
|
352 |
321 |
$0.00 |
| 99000 |
|
504 |
469 |
$0.00 |
| 90696 |
|
17 |
13 |
$0.00 |
| 90723 |
|
103 |
89 |
$0.00 |
| 90647 |
|
84 |
73 |
$0.00 |